Skip to content
OpenCapital
Get started

Tenet Healthcare THC Net Cost Report Settlements Receivable (Payable) And Valuation Allowances

Other financials

Income statement

See full
Revenue$5.4B+2.8%
Operating income$1.3B+37.4%
Net income$906.0M+45.7%
EPS (diluted)$8.01+87.6%

Balance sheet

See full
Cash & equivalents$3.0B-1.1%
Total debt$13.3B+0.2%
Total equity$4.8B+15.1%
Total assets$31.2B+6.7%

Cash flow

See full
Operating cash flow$1.6B+101%
CapEx$180.0M+4.0%
Free cash flow$1.5B+128%

Valuation

See full
Market cap$14.86B—
Enterprise value$25.19B—
P/E5.6×—
P/S0.7×—

Profitability

See full
Operating margin18%+0.4pp
Net margin12.4%+0.9pp
FCF margin15.6%—

Returns & leverage

See full
Return on equity58.9%-2.7pp
Debt / equity2.8×-0.4×
Current ratio1.4×-0.4×

Where this comes from

Reported directly by Tenet Healthcare in its filing.

Tagged under the XBRL concept thc:NetCostReportSettlementsReceivablePayableAndValuationAllowances.

The official record: Tenet Healthcare’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tenet Healthcare's net cost report settlements receivable (payable) and valuation allowances.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tenet Healthcare's net cost report settlements receivable (payable) and valuation allowances?
Tenet Healthcare (THC) reported net cost report settlements receivable (payable) and valuation allowances of $0 in Q1 2026.
How has Tenet Healthcare's net cost report settlements receivable (payable) and valuation allowances changed year-over-year?
Tenet Healthcare's net cost report settlements receivable (payable) and valuation allowances increased by 100.0% year-over-year, from -$4M to $0.
What is the long-term trend for Tenet Healthcare's net cost report settlements receivable (payable) and valuation allowances?
Over 2 years (2023 to 2025), Tenet Healthcare's net cost report settlements receivable (payable) and valuation allowances has grown at a -85.4% compound annual growth rate (CAGR), from -$47M to $1M.